Etaracizumab (Synonyms: LM 609; MEDI 523; Anti-αvβ3 Integrin Recombinant Antibody) |
Catalog No.GC26328 |
Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 892553-42-3
Sample solution is provided at 25 µL, 10mM.
Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer.
References:
[1]. Hersey P, et al. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma. Cancer. 2010 Mar 15;116(6):1526-34.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *